[Guidelines for the management of refractory nephrotic syndrome--from investigations between 1997 and 2001--research project team for progressive renal lesions in the Ministry of Health, Labor and Welfare, Japan].
Sakai
Hideto
H
Kurokawa
Kiyoshi
K
Saito
Takao
T
Shiiki
Hideo
H
Nishi
Shinichi
S
Mitarai
Tetsuya
T
Yokoyama
Hitoshi
H
Yoshimura
Ashio
A
Yorioka
Noriaki
N
D001781:Blood Component Removal; D002423:Cause of Death; D002699:Chlorambucil / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D015433:Glomerulonephritis, Membranous / Q000150:complications / Q000453:epidemiology / Q000628:therapy*; D005923:Glomerulosclerosis, Focal Segmental / Q000150:complications / Q000453:epidemiology / Q000628:therapy*; D006801:Humans; D007564:Japan / Q000453:epidemiology; D009404:Nephrotic Syndrome / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D017410:Practice Guidelines as Topic; D011239:Prednisolone / Q000008:administration & dosage; D011379:Prognosis; D012263:Ribonucleosides / Q000008:administration & dosage; D011795:Surveys and Questionnaires; D013997:Time Factors
D012263:Ribonucleosides; D002699:Chlorambucil; C010052:mizoribine; D003520:Cyclophosphamide; D011239:Prednisolone